GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation
OSL:GENT • NO0010748866
38 NOK
0 (0%)
Last: Mar 11, 2026, 07:00 PM
This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Taking everything into account, GENT scores 6 out of 10 in our fundamental rating. GENT was compared to 65 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT has a correct valuation and a medium growth rate.
1. GENT.OL Profitability Analysis
1.1 Basic Checks
- GENT had positive earnings in the past year.
- In the past year GENT had a positive cash flow from operations.
- In multiple years GENT reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
- GENT has a better Return On Assets (5.13%) than 66.15% of its industry peers.
- GENT has a Return On Equity (6.47%) which is in line with its industry peers.
- Looking at the Return On Invested Capital, with a value of 8.73%, GENT is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROIC | 8.73% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GENT has a Profit Margin (7.51%) which is in line with its industry peers.
- With a decent Operating Margin value of 14.42%, GENT is doing good in the industry, outperforming 66.15% of the companies in the same industry.
- GENT's Gross Margin of 55.64% is in line compared to the rest of the industry. GENT outperforms 43.08% of its industry peers.
- GENT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
2. GENT.OL Health Analysis
2.1 Basic Checks
- GENT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- GENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 7.65 indicates that GENT is not in any danger for bankruptcy at the moment.
- GENT has a better Altman-Z score (7.65) than 90.77% of its industry peers.
- GENT has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.61, GENT belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
- A Debt/Equity ratio of 0.09 indicates that GENT is not too dependend on debt financing.
- GENT has a Debt to Equity ratio of 0.09. This is amongst the best in the industry. GENT outperforms 81.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 7.65 |
ROIC/WACC1.02
WACC8.53%
2.3 Liquidity
- GENT has a Current Ratio of 5.40. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT's Current ratio of 5.40 is amongst the best of the industry. GENT outperforms 98.46% of its industry peers.
- A Quick Ratio of 3.81 indicates that GENT has no problem at all paying its short term obligations.
- GENT's Quick ratio of 3.81 is amongst the best of the industry. GENT outperforms 95.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 |
3. GENT.OL Growth Analysis
3.1 Past
- The earnings per share for GENT have decreased strongly by -70.75% in the last year.
- Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 16.07% in the last year.
- The Revenue has been growing by 22.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
3.2 Future
- Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 79.21% on average per year.
- The Revenue is expected to grow by 19.00% on average over the next years. This is quite good.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GENT.OL Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 44.71, the valuation of GENT can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of GENT is on the same level as its industry peers.
- GENT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.15.
- A Price/Forward Earnings ratio of 14.22 indicates a correct valuation of GENT.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT indicates a rather cheap valuation: GENT is cheaper than 81.54% of the companies listed in the same industry.
- GENT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.71 | ||
| Fwd PE | 14.22 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 61.54% of the companies listed in the same industry.
- GENT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GENT is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.41 | ||
| EV/EBITDA | 14.45 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 79.21% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%
5. GENT.OL Dividend Analysis
5.1 Amount
- GENT has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
- The stock price of GENT dropped by -34.00% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 1.01, GENT pays a bit more dividend than its industry peers.
- GENT's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- GENT pays out 46.54% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Fundamentals: All Metrics, Ratios and Statistics
OSL:GENT (3/11/2026, 7:00:00 PM)
38
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap585.96M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (69.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-17.56%
Revenue NY rev (3m)-17.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.71 | ||
| Fwd PE | 14.22 | ||
| P/S | 3.32 | ||
| P/FCF | 18.41 | ||
| P/OCF | 13.76 | ||
| P/B | 2.86 | ||
| P/tB | 3.46 | ||
| EV/EBITDA | 14.45 |
EPS(TTM)0.85
EY2.24%
EPS(NY)2.67
Fwd EY7.03%
FCF(TTM)2.06
FCFY5.43%
OCF(TTM)2.76
OCFY7.27%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.22
PEG (5Y)N/A
Graham Number15.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROCE | 11.34% | ||
| ROIC | 8.73% | ||
| ROICexc | 16.54% | ||
| ROICexgc | 23.72% | ||
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% | ||
| FCFM | 18.03% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 118.04% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.21% | ||
| Profit Quality | 240.13% | ||
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 | ||
| Altman-Z | 7.65 |
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
How financially healthy is GENTIAN DIAGNOSTICS ASA?
The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.